A simple, precise, accurate, and reliable HPTLC method has been developed and validated for the analysis of EPE-Eperisone hydrochloride and PCM-Paracetamol in their combined dosage form. Identification and analysis were performed on 100?mm × 100?mm layer thickness 0.2?mm, precoated silica gel G60-F254 aluminum sheet, prewashed with methanol, and dried in an oven at 50°C for 5 min. Toluene : methanol : ethyl acetate : glacial acetic acid (4?:?3.5?:?2.5?:?0.05) (v/v/v/v) was used as mobile phase. Calibration plots were established showing the dependence of response (peak area) on the amount chromatographed. The validated calibration ranges were 200–700?ng/spot and 1300–4550?ng/spot for EPE and PCM with correlation coefficient (R2) 0.994 and 0.996, respectively. Average % recovery was between 98.61–100.94% and 99.18–100.57% for EPE and PCM, respectively. The spots were scanned at 248?nm in a reflectance mode. The proposed method was validated as per ICH guidelines and successfully applied to the estimation of EPE and PCM in their combined tablet dosage form. 1. Introduction EPE is chemically (2RS)-1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)propan-1-one and hydrochloride (1?:?1) (Figure 1(a)) [1, 2]. Eperisone HCl is a centrally acting muscle relaxant; it acts at the level of spinal cord by blocking sodium channels and calcium channels. Eperisone HCl exerts its spinal reflex inhibitory action predominantly via a presynaptic inhibition of the transmitter release from the primary afferent endings via a combined action on voltage-gated sodium and calcium channels. Eperisone HCl increases the blood supply to skeletal muscles; this action is noteworthy since a muscle contracture may compress the small blood vessels and induce an ischemia leading to release of pain stimulating compounds [3]. EPE is official in Japanese pharmacopoeia [1]. Chemically PCM is N-(4-hydroxyphenyl)acetamide (Figure 1(b)). Paracetamol is a weak inhibitor of PG-Prostaglandin synthesis of COX-1 and COX-2. Cyclooxygenase serves as a pain activator, is responsible for the biosynthesis of prostaglandins, is used for the relief of headaches, fever, pains, and is a major ingredient in numerous cold and flu remedies [4]. Paracetamol is official in Japanese Pharmacopoeia [1], British Pharmacopoeia [5], United States Pharmacopoeia [6], and Indian Pharmacopoeia [7]. Figure 1: Chemical structure of (a) EPE and (b) PCM. The review of the literature revealed that analytical methods involving spectrophotometry [8], LC-ESI-MS [9], have been reported for EPE in single form and in combination with other
References
[1]
Japanese Pharmacopoeia, Government of Japan, The Ministry of Health, Labour and Welfare, 16th edition.
[2]
The Merck index, An Encyclopedia of Chemicals, Drugs and Biological, Merck Research Laboratories, 13th edition, 2006.
[3]
A. Beltrame, S. Grangiè, and L. Guerra, “Clinical experience with eperisone in the treatment of acute low back pain,” Minerva Medica, vol. 99, no. 4, pp. 347–352, 2008.
[4]
K. D. Tripathi, Essentials of Medical Pharmacology, vol. 1, Jaypee Brothers, 5th edition, 2008.
[5]
British Pharmacopoeia, vol. 2, Stationery Office on Behalf of the Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK, 2011.
[6]
United States Pharmacopoeia and National Formulary, The United States Pharmacopoeia Convention, 24th Asian edition.
[7]
Indian Pharmacopoeia, vol. 3, Government of India, Ministry of Health & Family Welfare, the Controller & Publication, Delhi, India, 2010.
[8]
P. U. Patel, S. K. Patel, and U. J. Patel, “Spectrophotometric method for simultaneous estimation of eperisone HCl and diclofenac sodium in synthetic mixture,” International Research Journal of Pharmacy, vol. 3, no. 9, pp. 203–206, 2012.
[9]
Y. Zhang, L. Ding, X. Wei, S. Zhang, and J. Sheng, “Rapid and sensitive liquid chromatography-electrospray ionization-mass spectrometry method for the determination of eperisone in human plasma: method and clinical applications,” Journal of Chromatographic Science, vol. 42, no. 5, pp. 254–258, 2004.
[10]
M. S. Kondawar, R. R. Shah, J. J. Waghmare, N. D. Shah, and M. K. Malusare, “UV spectrophotometric estimation of paracetamol and lornoxicam in bulk drug and tablet dosage form using multiwavelength method,” International Journal of PharmTech Research, vol. 3, no. 3, pp. 1603–1608, 2011.
[11]
R. Sawant, L. Bhangale, R. Joshi, and P. Lanke, “Validated spectrophotometric methods for simultaneous estimation of Paracetamol, Domperidone and Tramadol HCl in pure and tablet dosage form,” Journal of Chemical Metrology, vol. 4, no. 1, pp. 21–27, 2010.
[12]
K. Kalra, S. Naik, G. Jarmal, and N. Mishra, “Spectrophotometric method for simultaneous estimation of paracetamol and domperidone in tablet formulation,” Asian Journal of Research in Chemistry, vol. 2, no. 2, pp. 112–114, 2009.
[13]
C. Narajji, H. R. Patel, M. D. Karvekar, and A. R. S. Babu, “Simultaneous estimation of aceclofenac, paracetamol and tizanidine in their combined dosage forms by spectrophotometric and RP- HPLC method,” Journal of Analytical and Bioanalytical Techniques, vol. 2, article 123, 2011.
[14]
S. Mahaparale, R. S. Telekone, R. P. Raut, S. S. Damle, and P. V. Kasture, “Simultaneous spectrophotometric determination of drotaverine hydrochloride and paracetamol in tablet,” Indian Journal of Pharmaceutical Sciences, vol. 72, no. 1, pp. 133–136, 2010.
[15]
R. B. Prasanna and M. S. Reddy, “RP-HPLC method for simultaneous estimation of paracetamol and ibuprofen in tablets,” Asian Journal of Research in Chemistry, vol. 2, no. 1, pp. 70–72, 2009.
[16]
L. Monser and F. Darghouth, “Simultaneous LC determination of paracetamol and related compounds in pharmaceutical formulations using a carbon-based column,” Journal of Pharmaceutical and Biomedical Analysis, vol. 27, no. 6, pp. 851–860, 2002.
[17]
N. P. Dudhane, M. J. Umekar, and R. T. Lohiya, “Validated RP-HPLC method for estimation of metoclopramide hydrochloride and paracetamol in solid dosage form,” Journal of Pharmaceutical Research, vol. 3, no. 12, pp. 3064–3066, 2010.
[18]
A. Yadav, R. Singh, S. Mathur, P. Saini, and G. Singh, “A simple and sensitive HPTLC method for simultaneous analysis of domperidone and paracetamol in tablet dosage forms,” Journal of Planar Chromatography, vol. 22, no. 6, pp. 421–424, 2009.
[19]
P. B. Deshpanday, V. S. Gandhi, and S. Y. Bhangale, “HPTLC method for simultaneous estimation of etoricoxib and paracetamol in combined tablet dosage,” Journal of Pharmaceutical and Biomedical Analysis, vol. 3, pp. 1–5, 2010.
[20]
ICH Harmonized Tripartite Guidelines, Validation of Analytical Procedures: Text and Methodology, Q2 (R1), Geneva, Switzerland, 2005.